#METABOLOMICS WORKBENCH mahpic_infodepo_20170220_114434 DATATRACK_ID:851 STUDY_ID:ST000578 ANALYSIS_ID:AN000889 PROJECT_ID:PR000384 VERSION 1 CREATED_ON April 5, 2017, 12:51 pm #PROJECT PR:PROJECT_TITLE The Malaria Host-Pathogen Interaction Center (MaHPIC) PR:PROJECT_TYPE Systems Biology PR:PROJECT_SUMMARY The Malaria Host-Pathogen Interaction Center (MaHPIC) is a transdisciplinary PR:PROJECT_SUMMARY malaria systems biology research program supported by an NIH/NIAID contract (# PR:PROJECT_SUMMARY HHSN272201200031C; see http://www.systemsbiology.emory.edu). The MaHPIC PR:PROJECT_SUMMARY generates many data types (e.g., clinical, parasitological, metabolomics, PR:PROJECT_SUMMARY functional genomics, lipidomics, proteomics, immune response) and mathematical PR:PROJECT_SUMMARY models, to iteratively test and develop hypotheses related to the complex PR:PROJECT_SUMMARY host-parasite dynamics in the course of malaria in non-human primates, and PR:PROJECT_SUMMARY metabolomics data via collaborations with investigators conducting clinical PR:PROJECT_SUMMARY studies in malaria endemic countries, with the overarching goal of better PR:PROJECT_SUMMARY understanding human disease, pathogenesis, and immunity. Curation and PR:PROJECT_SUMMARY maintenance of all data and metadata are the responsibility of the MaHPIC. PR:INSTITUTE Emory University PR:DEPARTMENT School of Medicine, Vaccine Center at Yerkes PR:LAST_NAME Galinski PR:FIRST_NAME Mary PR:ADDRESS Emory University, 954 Gatewood Rd, Room 208, Atlanta, GA 30329 PR:EMAIL mgalins@emory.edu PR:PHONE None PR:FUNDING_SOURCE NIAID Contract: # HHSN272201200031C #STUDY ST:STUDY_TITLE Experiment HuA: Metabolomics of plasma samples from humans infected ST:STUDY_TITLE with Plasmodium vivax strain. ST:STUDY_TYPE Longitudinal study and treatment of multiple individuals with Chloroquine ST:STUDY_SUMMARY Patients with vivax malaria were enrolled in this study from June 2011 to ST:STUDY_SUMMARY December 2012 at the Fundacão de Medicina Tropical Doutor Heitor Vieira Dourado ST:STUDY_SUMMARY (FMT-HVD), an infectious disease referral center located in Manaus, Western ST:STUDY_SUMMARY Brazilian Amazon. This study, which required a 42-day follow-up period, was ST:STUDY_SUMMARY approved by the FMT-HVD Institutional Review Board and the Brazilian National ST:STUDY_SUMMARY Ethics Committee (CONEP) (IRB approval #: CAAE: 12516713.8.0000.0005). All ST:STUDY_SUMMARY protocols and documentation were reviewed and sample shipments approved by the ST:STUDY_SUMMARY Emory IRB. Male and female patients were eligible for inclusion if aged 6 months ST:STUDY_SUMMARY to 60 years, bodyweight ?5 kg, presenting a blood parasite density from 250 to ST:STUDY_SUMMARY 100,000 parasites/microliter and axillary temperature ?37.5°C or history of ST:STUDY_SUMMARY fever in the last 48 hours. Exclusion criteria were: use of antimalarials in the ST:STUDY_SUMMARY previous 30 days, refusal to be followed up for 42 days and any clinical ST:STUDY_SUMMARY complication. Patients received supervised treatment with 25 mg/kg of ST:STUDY_SUMMARY chloroquine (CQ) phosphate over a 3-day period (10 mg/kg on day 0 and 7.5 mg/kg ST:STUDY_SUMMARY on days 1 and 2). Primaquine (0.5 mg/kg per day for 7 days) was prescribed at ST:STUDY_SUMMARY the end of the 42-day follow-up period. Patients who vomited the first dose ST:STUDY_SUMMARY within 30 minutes after drug ingestion were re-treated with the same dose. ST:STUDY_SUMMARY Patients were evaluated on days 0, 1, 2, 3, 7, 14, 28 and 42 and, if they felt ST:STUDY_SUMMARY ill, at any time during the study period. Blood smear readings, complete blood ST:STUDY_SUMMARY counts, and diagnostic polymerase chain reaction (PCR) amplifications were ST:STUDY_SUMMARY performed at all time points. Three aliquots of 100 µL of whole blood from the ST:STUDY_SUMMARY day of a recurrence were spotted onto filter paper for later analysis by high ST:STUDY_SUMMARY performance liquid chromatography (HPLC) to estimate the levels of CQ and ST:STUDY_SUMMARY desethylchloroquine (DCQ) as previously described. In this study, CQ-resistance ST:STUDY_SUMMARY with parasitological failure was defined as parasite recurrence in the presence ST:STUDY_SUMMARY of plasma concentrations of CQ and DSQ higher than 100 ng/mL and microsatellite ST:STUDY_SUMMARY analysis revealing the presence of the same clonal nature at diagnosis and ST:STUDY_SUMMARY recurrence. The CQ-sensitive control group consisted of patients with no ST:STUDY_SUMMARY parasitemia recurring during follow-up period. A group of 20 healthy individuals ST:STUDY_SUMMARY from Brazil was used as non-malarial control group. Within the MaHPIC, this ST:STUDY_SUMMARY project is known as ‘Experiment HuA’. This dataset was produced by Dean ST:STUDY_SUMMARY Jones at Emory University. ST:INSTITUTE Emory University ST:DEPARTMENT School of Medicine, Vaccine Center at Yerkes ST:LAST_NAME Galinksi ST:FIRST_NAME Mary ST:ADDRESS Emory University, Yerkes National Primate Research Center, 954 Gatewood Rd, Room ST:ADDRESS 003, Atlanta, GA 30329 ST:EMAIL mahpic@emory.edu ST:PHONE None ST:NUM_GROUPS 273 ST:TOTAL_SUBJECTS 220 #SUBJECT SU:SUBJECT_TYPE Human SU:SUBJECT_SPECIES Homo sapiens SU:TAXONOMY_ID 9606 SU:SUBJECT_COMMENTS 220 subjects #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data SUBJECT_SAMPLE_FACTORS 92187 2008235 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=<10; Gender=Male; wbc(cells/uL)=12200; hgb(g/dL)=11.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92187 2007260 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:Resistant Age=<10; Gender=Male; wbc(cells/uL)=7600; hgb(g/dL)=10.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92196 2007278 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=46; Gender=Female; wbc(cells/uL)=6200; hgb(g/dL)=11.4; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92261 2008603 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=39; Gender=Male; wbc(cells/uL)=7500; hgb(g/dL)=14; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92262 2008614 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=35; Gender=Male; wbc(cells/uL)=5800; hgb(g/dL)=14.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92262 2008613 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=35; Gender=Male; wbc(cells/uL)=5600; hgb(g/dL)=14.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92263 2008618 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=<10; Gender=Male; wbc(cells/uL)=6600; hgb(g/dL)=11.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92264 2008621 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=36; Gender=Male; wbc(cells/uL)=6230; hgb(g/dL)=15.47; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92265 2008622 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=21; Gender=Male; wbc(cells/uL)=4070; hgb(g/dL)=13.42; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92266 2008623 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=59; Gender=Female; wbc(cells/uL)=6800; hgb(g/dL)=11.8; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92267 2008624 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=10; Gender=Female; wbc(cells/uL)=5100; hgb(g/dL)=11.4; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92268 2008625 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=46; Gender=Male; wbc(cells/uL)=5100; hgb(g/dL)=12.9; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92268 2008626 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=46; Gender=Male; wbc(cells/uL)=8000; hgb(g/dL)=12; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92269 2008627 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=38; Gender=Female; wbc(cells/uL)=9100; hgb(g/dL)=14.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92270 2008628 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=43; Gender=Female; wbc(cells/uL)=7600; hgb(g/dL)=14.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92271 2008629 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=21; Gender=Female; wbc(cells/uL)=5800; hgb(g/dL)=13.9; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92271 2008630 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=21; Gender=Female; wbc(cells/uL)=8300; hgb(g/dL)=12.1; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92275 2008631 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=28; Gender=Male; wbc(cells/uL)=7000; hgb(g/dL)=13.1; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92278 2008651 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=35; Gender=Female; wbc(cells/uL)=6000; hgb(g/dL)=12.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92280 2008652 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=22; Gender=Female; wbc(cells/uL)=6200; hgb(g/dL)=12.4; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92280 2008653 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=22; Gender=Female; wbc(cells/uL)=6000; hgb(g/dL)=12.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92281 2008654 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=64; Gender=Male; wbc(cells/uL)=8400; hgb(g/dL)=14.8; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92282 2008660 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=38; Gender=Male; wbc(cells/uL)=2600; hgb(g/dL)=13.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92284 2008674 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=41; Gender=Female; wbc(cells/uL)=4700; hgb(g/dL)=13.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92284 2008675 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=41; Gender=Female; wbc(cells/uL)=9400; hgb(g/dL)=13.1; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92285 2008676 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=50; Gender=Male; wbc(cells/uL)=2400; hgb(g/dL)=14.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92285 2008677 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=11; Gender=Female; wbc(cells/uL)=4700; hgb(g/dL)=14.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92286 2008678 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=15; Gender=Male; wbc(cells/uL)=1900; hgb(g/dL)=13.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92287 2008679 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=15; Gender=Male; wbc(cells/uL)=4700; hgb(g/dL)=12.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92288 2008680 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=36; Gender=Male; wbc(cells/uL)=6800; hgb(g/dL)=14.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92290 2008700 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=48; Gender=Male; wbc(cells/uL)=7740; hgb(g/dL)=14.67; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92290 2008699 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=45; Gender=Male; wbc(cells/uL)=4900; hgb(g/dL)=14.9; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92291 2008702 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=48; Gender=Male; wbc(cells/uL)=4400; hgb(g/dL)=14.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92293 2008709 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=33; Gender=Male; wbc(cells/uL)=5700; hgb(g/dL)=16.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92294 2008710 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=22; Gender=Male; wbc(cells/uL)=2500; hgb(g/dL)=15.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92296 2008712 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=54; Gender=Male; wbc(cells/uL)=4600; hgb(g/dL)=14; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92296 2008715 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=54; Gender=Male; wbc(cells/uL)=6700; hgb(g/dL)=15.1; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92297 2008721 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=12; Gender=Male; wbc(cells/uL)=4600; hgb(g/dL)=12.1; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92298 2008722 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=23; Gender=Male; wbc(cells/uL)=6400; hgb(g/dL)=13.8; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92299 2008791 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=42; Gender=Male; wbc(cells/uL)=7800; hgb(g/dL)=13.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92299 2008727 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=42; Gender=Male; wbc(cells/uL)=7000; hgb(g/dL)=14.2; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92300 2009109 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=32; Gender=Male; wbc(cells/uL)=2300; hgb(g/dL)=9.9; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92301 2009110 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=41; Gender=Male; wbc(cells/uL)=6700; hgb(g/dL)=14; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92302 2009204 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=13; Gender=Male; wbc(cells/uL)=4700; hgb(g/dL)=12; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92302 2009203 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=13; Gender=Male; wbc(cells/uL)=4530; hgb(g/dL)=12.42; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92303 2009212 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=42; Gender=Male; wbc(cells/uL)=6400; hgb(g/dL)=13.9; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92305 2009225 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=59; Gender=Male; wbc(cells/uL)=6700; hgb(g/dL)=14.8; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92306 2009227 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=16; Gender=Male; wbc(cells/uL)=8300; hgb(g/dL)=12.9; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92306 2009226 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=16; Gender=Male; wbc(cells/uL)=2600; hgb(g/dL)=13.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92307 2009228 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=63; Gender=Male; wbc(cells/uL)=7400; hgb(g/dL)=13.8; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92309 2009233 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=22; Gender=Male; wbc(cells/uL)=4600; hgb(g/dL)=12.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92310 2009249 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=43; Gender=Male; wbc(cells/uL)=4700; hgb(g/dL)=12.2; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92310 2009250 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=43; Gender=Male; wbc(cells/uL)=6200; hgb(g/dL)=14; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92311 2009253 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=32; Gender=Male; wbc(cells/uL)=7480; hgb(g/dL)=13.89; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92312 2009254 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=27; Gender=Male; wbc(cells/uL)=6400; hgb(g/dL)=13.9; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92313 2009256 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=25; Gender=Male; wbc(cells/uL)=7200; hgb(g/dL)=15.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92313 2009255 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=25; Gender=Male; wbc(cells/uL)=7480; hgb(g/dL)=15.13; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92314 2009261 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=62; Gender=Male; wbc(cells/uL)=7800; hgb(g/dL)=14.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92315 2009262 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=<10; Gender=Male; wbc(cells/uL)=9400; hgb(g/dL)=10.2; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92316 2009264 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:Resistant Age=37; Gender=Male; wbc(cells/uL)=5000; hgb(g/dL)=14.4; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92316 2009263 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=37; Gender=Male; wbc(cells/uL)=4900; hgb(g/dL)=14; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92317 2009265 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=57; Gender=Male; wbc(cells/uL)=43220; hgb(g/dL)=12.78; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92318 2009266 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Susceptible Age=25; Gender=Female; wbc(cells/uL)=5400; hgb(g/dL)=11.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92319 2009267 Current Malaria Infection:P.Vivax | Prior Malaria Infection:N/A | Chloroquine Resistance:Resistant Age=10; Gender=Male; wbc(cells/uL)=4900; hgb(g/dL)=9.4; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92430 2015542 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=75.1; Gender=Male; wbc(cells/uL)=6500; hgb(g/dL)=10.7; rbc(cells/uL)=3740000 SUBJECT_SAMPLE_FACTORS 92431 2015543 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=59.8; Gender=Male; wbc(cells/uL)=13700; hgb(g/dL)=16.9; rbc(cells/uL)=4920000 SUBJECT_SAMPLE_FACTORS 92432 2015544 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=22.4; Gender=Female; wbc(cells/uL)=6900; hgb(g/dL)=10; rbc(cells/uL)=3510000 SUBJECT_SAMPLE_FACTORS 92433 2015545 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=15.9; Gender=Female; wbc(cells/uL)=8500; hgb(g/dL)=10; rbc(cells/uL)=3930000 SUBJECT_SAMPLE_FACTORS 92434 2015546 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=37.2; Gender=Female; wbc(cells/uL)=3600; hgb(g/dL)=8.9; rbc(cells/uL)=3960000 SUBJECT_SAMPLE_FACTORS 92435 2015547 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=19.8; Gender=Male; wbc(cells/uL)=4700; hgb(g/dL)=13.5; rbc(cells/uL)=4340000 SUBJECT_SAMPLE_FACTORS 92436 2015548 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=45.6; Gender=Male; wbc(cells/uL)=7600; hgb(g/dL)=6.5; rbc(cells/uL)=2120000 SUBJECT_SAMPLE_FACTORS 92437 2015549 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=33.2; Gender=Female; wbc(cells/uL)=5900; hgb(g/dL)=9; rbc(cells/uL)=3300000 SUBJECT_SAMPLE_FACTORS 92438 2015550 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=13.3; Gender=Male; wbc(cells/uL)=2600; hgb(g/dL)=9.8; rbc(cells/uL)=3740000 SUBJECT_SAMPLE_FACTORS 92439 2015551 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=30.3; Gender=Male; wbc(cells/uL)=5800; hgb(g/dL)=8.6; rbc(cells/uL)=2910000 SUBJECT_SAMPLE_FACTORS 92440 2015552 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=53; Gender=Male; wbc(cells/uL)=4900; hgb(g/dL)=13; rbc(cells/uL)=4200000 SUBJECT_SAMPLE_FACTORS 92441 2015553 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=50.3; Gender=Female; wbc(cells/uL)=3300; hgb(g/dL)=10.7; rbc(cells/uL)=4190000 SUBJECT_SAMPLE_FACTORS 92442 2015554 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=<10; Gender=Male; wbc(cells/uL)=3600; hgb(g/dL)=7.9; rbc(cells/uL)=2750000 SUBJECT_SAMPLE_FACTORS 92443 2015639 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=40.7; Gender=Female; wbc(cells/uL)=5100; hgb(g/dL)=7; rbc(cells/uL)=2490000 SUBJECT_SAMPLE_FACTORS 92444 2015640 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=66; Gender=Female; wbc(cells/uL)=2900; hgb(g/dL)=13; rbc(cells/uL)=4890000 SUBJECT_SAMPLE_FACTORS 92445 2015641 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=32.3; Gender=Female; wbc(cells/uL)=6100; hgb(g/dL)=9; rbc(cells/uL)=3060000 SUBJECT_SAMPLE_FACTORS 92446 2016027 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=23.4; Gender=Male; wbc(cells/uL)=3200; hgb(g/dL)=15.1; rbc(cells/uL)=5420000 SUBJECT_SAMPLE_FACTORS 92447 2015643 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=22.7; Gender=Female; wbc(cells/uL)=6900; hgb(g/dL)=8.9; rbc(cells/uL)=3120000 SUBJECT_SAMPLE_FACTORS 92448 2015644 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=<10; Gender=Male; wbc(cells/uL)=6; hgb(g/dL)=8; rbc(cells/uL)=3220000 SUBJECT_SAMPLE_FACTORS 92449 2015645 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=35.2; Gender=Male; wbc(cells/uL)=1800; hgb(g/dL)=14; rbc(cells/uL)=4370000 SUBJECT_SAMPLE_FACTORS 92450 2015646 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=23.4; Gender=Female; wbc(cells/uL)=4500; hgb(g/dL)=13.6; rbc(cells/uL)=4660000 SUBJECT_SAMPLE_FACTORS 92451 2015647 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=22.6; Gender=Female; wbc(cells/uL)=6600; hgb(g/dL)=10.5; rbc(cells/uL)=3900000 SUBJECT_SAMPLE_FACTORS 92452 2015648 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=31.3; Gender=Male; wbc(cells/uL)=5700; hgb(g/dL)=13.5; rbc(cells/uL)=4670000 SUBJECT_SAMPLE_FACTORS 92453 2015649 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=34.3; Gender=Male; wbc(cells/uL)=4200; hgb(g/dL)=15.6; rbc(cells/uL)=5000000 SUBJECT_SAMPLE_FACTORS 92454 2015650 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=26.1; Gender=Male; wbc(cells/uL)=6100; hgb(g/dL)=13.9; rbc(cells/uL)=4850000 SUBJECT_SAMPLE_FACTORS 92455 2015651 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=<10; Gender=Male; wbc(cells/uL)=5000; hgb(g/dL)=5.2; rbc(cells/uL)=1900000 SUBJECT_SAMPLE_FACTORS 92456 2015652 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=26.3; Gender=Male; wbc(cells/uL)=10700; hgb(g/dL)=10.6; rbc(cells/uL)=2330000 SUBJECT_SAMPLE_FACTORS 92457 2015653 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=34; Gender=Male; wbc(cells/uL)=6000; hgb(g/dL)=15.8; rbc(cells/uL)=5520000 SUBJECT_SAMPLE_FACTORS 92458 2015654 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=<10; Gender=Female; wbc(cells/uL)=2400; hgb(g/dL)=10.2; rbc(cells/uL)=3700000 SUBJECT_SAMPLE_FACTORS 92459 2015655 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=50.4; Gender=Male; wbc(cells/uL)=5800; hgb(g/dL)=10.1; rbc(cells/uL)=3610000 SUBJECT_SAMPLE_FACTORS 92460 2015656 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=47.3; Gender=Male; wbc(cells/uL)=4500; hgb(g/dL)=10.7; rbc(cells/uL)=3920000 SUBJECT_SAMPLE_FACTORS 92461 2015657 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=28.5; Gender=Male; wbc(cells/uL)=2500; hgb(g/dL)=15.6; rbc(cells/uL)=5400000 SUBJECT_SAMPLE_FACTORS 92462 2015658 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=19.7; Gender=Female; wbc(cells/uL)=19400; hgb(g/dL)=7.9; rbc(cells/uL)=2630000 SUBJECT_SAMPLE_FACTORS 92463 2015659 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=48.8; Gender=Female; wbc(cells/uL)=5600; hgb(g/dL)=9.8; rbc(cells/uL)=3480000 SUBJECT_SAMPLE_FACTORS 92464 2015660 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=<10; Gender=Female; wbc(cells/uL)=2100; hgb(g/dL)=6.8; rbc(cells/uL)=2690000 SUBJECT_SAMPLE_FACTORS 92465 2015661 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=45.9; Gender=Male; wbc(cells/uL)=4900; hgb(g/dL)=12.9; rbc(cells/uL)=4630000 SUBJECT_SAMPLE_FACTORS 92466 2015662 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=39; Gender=Female; wbc(cells/uL)=8700; hgb(g/dL)=10.5; rbc(cells/uL)=4030000 SUBJECT_SAMPLE_FACTORS 92467 2015663 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=31.6; Gender=Male; wbc(cells/uL)=6000; hgb(g/dL)=13.1; rbc(cells/uL)=4910000 SUBJECT_SAMPLE_FACTORS 92468 2015664 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=48.4; Gender=Male; wbc(cells/uL)=7200; hgb(g/dL)=14.8; rbc(cells/uL)=5870000 SUBJECT_SAMPLE_FACTORS 92469 2015665 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=23.1; Gender=Male; wbc(cells/uL)=4500; hgb(g/dL)=13; rbc(cells/uL)=4630000 SUBJECT_SAMPLE_FACTORS 92470 2015666 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=47.6; Gender=Male; wbc(cells/uL)=3600; hgb(g/dL)=14.9; rbc(cells/uL)=5100000 SUBJECT_SAMPLE_FACTORS 92471 2015667 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=31.6; Gender=Female; wbc(cells/uL)=5500; hgb(g/dL)=13.1; rbc(cells/uL)=5100000 SUBJECT_SAMPLE_FACTORS 92472 2015668 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=33.3; Gender=Male; wbc(cells/uL)=4800; hgb(g/dL)=14.1; rbc(cells/uL)=5470000 SUBJECT_SAMPLE_FACTORS 92473 2015669 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=25.3; Gender=Male; wbc(cells/uL)=3800; hgb(g/dL)=14.9; rbc(cells/uL)=5420000 SUBJECT_SAMPLE_FACTORS 92474 2015670 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=28.8; Gender=Male; wbc(cells/uL)=6100; hgb(g/dL)=13.4; rbc(cells/uL)=4660000 SUBJECT_SAMPLE_FACTORS 92475 2015671 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=35.8; Gender=Male; wbc(cells/uL)=4800; hgb(g/dL)=13.1; rbc(cells/uL)=4840000 SUBJECT_SAMPLE_FACTORS 92476 2015672 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=21.8; Gender=Male; wbc(cells/uL)=7500; hgb(g/dL)=14.8; rbc(cells/uL)=5120000 SUBJECT_SAMPLE_FACTORS 92477 2015673 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=47.9; Gender=Female; wbc(cells/uL)=5900; hgb(g/dL)=10.6; rbc(cells/uL)=4260000 SUBJECT_SAMPLE_FACTORS 92478 2015674 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=36.2; Gender=Male; wbc(cells/uL)=5000; hgb(g/dL)=13; rbc(cells/uL)=4960000 SUBJECT_SAMPLE_FACTORS 92479 2015675 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=41.7; Gender=Male; wbc(cells/uL)=6300; hgb(g/dL)=14; rbc(cells/uL)=5230000 SUBJECT_SAMPLE_FACTORS 92480 2015784 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=25; Gender=Male; wbc(cells/uL)=4100; hgb(g/dL)=12.9; rbc(cells/uL)=4670000 SUBJECT_SAMPLE_FACTORS 92481 2015785 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=68.4; Gender=Male; wbc(cells/uL)=6100; hgb(g/dL)=10.9; rbc(cells/uL)=3950000 SUBJECT_SAMPLE_FACTORS 92482 2015786 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=46.3; Gender=Male; wbc(cells/uL)=8000; hgb(g/dL)=14.9; rbc(cells/uL)=5190000 SUBJECT_SAMPLE_FACTORS 92483 2015787 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=27.1; Gender=Male; wbc(cells/uL)=4100; hgb(g/dL)=9.4; rbc(cells/uL)=3500000 SUBJECT_SAMPLE_FACTORS 92484 2015788 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=30.6; Gender=Male; wbc(cells/uL)=7800; hgb(g/dL)=15.3; rbc(cells/uL)=5090000 SUBJECT_SAMPLE_FACTORS 92485 2015789 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=47; Gender=Male; wbc(cells/uL)=7800; hgb(g/dL)=15; rbc(cells/uL)=5280000 SUBJECT_SAMPLE_FACTORS 92486 2015790 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=23.4; Gender=Male; wbc(cells/uL)=6700; hgb(g/dL)=13.4; rbc(cells/uL)=4940000 SUBJECT_SAMPLE_FACTORS 92491 2015791 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=22.9; Gender=Male; wbc(cells/uL)=5600; hgb(g/dL)=13; rbc(cells/uL)=4320000 SUBJECT_SAMPLE_FACTORS 92492 2015792 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=37.5; Gender=Male; wbc(cells/uL)=7300; hgb(g/dL)=14.7; rbc(cells/uL)=5590000 SUBJECT_SAMPLE_FACTORS 92493 2015793 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=26.6; Gender=Male; wbc(cells/uL)=3900; hgb(g/dL)=15; rbc(cells/uL)=5500000 SUBJECT_SAMPLE_FACTORS 92494 2015794 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=38.8; Gender=Female; wbc(cells/uL)=3700; hgb(g/dL)=14; rbc(cells/uL)=4820000 SUBJECT_SAMPLE_FACTORS 92495 2015795 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=40.8; Gender=Male; wbc(cells/uL)=6500; hgb(g/dL)=14; rbc(cells/uL)=5320000 SUBJECT_SAMPLE_FACTORS 92496 2015796 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=28.8; Gender=Male; wbc(cells/uL)=6800; hgb(g/dL)=13.9; rbc(cells/uL)=5120000 SUBJECT_SAMPLE_FACTORS 92497 2015797 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=42.9; Gender=Male; wbc(cells/uL)=5300; hgb(g/dL)=13.1; rbc(cells/uL)=4340000 SUBJECT_SAMPLE_FACTORS 92498 2015798 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=37.5; Gender=Male; wbc(cells/uL)=4300; hgb(g/dL)=15; rbc(cells/uL)=5070000 SUBJECT_SAMPLE_FACTORS 92499 2015799 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=32.6; Gender=Female; wbc(cells/uL)=6000; hgb(g/dL)=14; rbc(cells/uL)=5440000 SUBJECT_SAMPLE_FACTORS 92500 2015800 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=62; Gender=Male; wbc(cells/uL)=5300; hgb(g/dL)=15.7; rbc(cells/uL)=5450000 SUBJECT_SAMPLE_FACTORS 92501 2015801 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=29.5; Gender=Male; wbc(cells/uL)=5800; hgb(g/dL)=14; rbc(cells/uL)=5390000 SUBJECT_SAMPLE_FACTORS 92502 2015802 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=36.5; Gender=Male; wbc(cells/uL)=3300; hgb(g/dL)=15.5; rbc(cells/uL)=5750000 SUBJECT_SAMPLE_FACTORS 92503 2015803 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=39.8; Gender=Male; wbc(cells/uL)=4300; hgb(g/dL)=14.6; rbc(cells/uL)=5580000 SUBJECT_SAMPLE_FACTORS 92504 2015804 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=27.8; Gender=Female; wbc(cells/uL)=7200; hgb(g/dL)=9.1; rbc(cells/uL)=3460000 SUBJECT_SAMPLE_FACTORS 92505 2015805 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=37.6; Gender=Male; wbc(cells/uL)=4500; hgb(g/dL)=13.9; rbc(cells/uL)=5130000 SUBJECT_SAMPLE_FACTORS 92506 2015806 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=65; Gender=Male; wbc(cells/uL)=5200; hgb(g/dL)=13.5; rbc(cells/uL)=4840000 SUBJECT_SAMPLE_FACTORS 92507 2015807 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=43.1; Gender=Male; wbc(cells/uL)=12000; hgb(g/dL)=6.4; rbc(cells/uL)=2160000 SUBJECT_SAMPLE_FACTORS 92508 2015808 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=34.8; Gender=Female; wbc(cells/uL)=5170; hgb(g/dL)=4.8; rbc(cells/uL)=1730000 SUBJECT_SAMPLE_FACTORS 92509 2015809 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=51.8; Gender=Female; wbc(cells/uL)=3900; hgb(g/dL)=13.4; rbc(cells/uL)=4310000 SUBJECT_SAMPLE_FACTORS 92510 2015810 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=20.4; Gender=Female; wbc(cells/uL)=3400; hgb(g/dL)=8.9; rbc(cells/uL)=3350000 SUBJECT_SAMPLE_FACTORS 92511 2015811 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=<10; Gender=Female; wbc(cells/uL)=4300; hgb(g/dL)=10.3; rbc(cells/uL)=3680000 SUBJECT_SAMPLE_FACTORS 92512 2015812 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=18.7; Gender=Male; wbc(cells/uL)=6300; hgb(g/dL)=15.5; rbc(cells/uL)=4980000 SUBJECT_SAMPLE_FACTORS 92513 2015813 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=<10; Gender=Male; wbc(cells/uL)=1300; hgb(g/dL)=10.1; rbc(cells/uL)=3460000 SUBJECT_SAMPLE_FACTORS 92514 2015814 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=49.3; Gender=Male; wbc(cells/uL)=6500; hgb(g/dL)=13.5; rbc(cells/uL)=5100000 SUBJECT_SAMPLE_FACTORS 92515 2015835 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=45.2; Gender=Female; wbc(cells/uL)=4600; hgb(g/dL)=13; rbc(cells/uL)=5310000 SUBJECT_SAMPLE_FACTORS 92516 2015836 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=48.5; Gender=Female; wbc(cells/uL)=3700; hgb(g/dL)=14.1; rbc(cells/uL)=4960000 SUBJECT_SAMPLE_FACTORS 92517 2015837 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=58.4; Gender=Male; wbc(cells/uL)=5700; hgb(g/dL)=15.3; rbc(cells/uL)=5040000 SUBJECT_SAMPLE_FACTORS 92518 2015838 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=53.7; Gender=Female; wbc(cells/uL)=3600; hgb(g/dL)=14.1; rbc(cells/uL)=5080000 SUBJECT_SAMPLE_FACTORS 92519 2015839 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=14.3; Gender=Female; wbc(cells/uL)=4100; hgb(g/dL)=13.4; rbc(cells/uL)=5190000 SUBJECT_SAMPLE_FACTORS 92520 2015840 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=37.6; Gender=Female; wbc(cells/uL)=5300; hgb(g/dL)=14.1; rbc(cells/uL)=4570000 SUBJECT_SAMPLE_FACTORS 92521 2015841 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=31; Gender=Male; wbc(cells/uL)=2800; hgb(g/dL)=14.9; rbc(cells/uL)=5000000 SUBJECT_SAMPLE_FACTORS 92522 2015842 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=28.9; Gender=Male; wbc(cells/uL)=2700; hgb(g/dL)=13; rbc(cells/uL)=4580000 SUBJECT_SAMPLE_FACTORS 92523 2015843 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=18.7; Gender=Male; wbc(cells/uL)=3600; hgb(g/dL)=13.4; rbc(cells/uL)=4610000 SUBJECT_SAMPLE_FACTORS 92524 2015844 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=27.4; Gender=Female; wbc(cells/uL)=5800; hgb(g/dL)=13.1; rbc(cells/uL)=5010000 SUBJECT_SAMPLE_FACTORS 92525 2015845 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=22.4; Gender=Male; wbc(cells/uL)=4500; hgb(g/dL)=13.4; rbc(cells/uL)=4950000 SUBJECT_SAMPLE_FACTORS 92526 2015846 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=13.7; Gender=Male; wbc(cells/uL)=2300; hgb(g/dL)=13.1; rbc(cells/uL)=5110000 SUBJECT_SAMPLE_FACTORS 92527 2015847 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=32.9; Gender=Male; wbc(cells/uL)=6400; hgb(g/dL)=12.9; rbc(cells/uL)=4610000 SUBJECT_SAMPLE_FACTORS 92528 2015848 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=54.3; Gender=Male; wbc(cells/uL)=5800; hgb(g/dL)=15.1; rbc(cells/uL)=5230000 SUBJECT_SAMPLE_FACTORS 92529 2015849 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=41.3; Gender=Male; wbc(cells/uL)=9500; hgb(g/dL)=14.8; rbc(cells/uL)=4790000 SUBJECT_SAMPLE_FACTORS 92530 2015850 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=18.1; Gender=Male; wbc(cells/uL)=7100; hgb(g/dL)=8.9; rbc(cells/uL)=3220000 SUBJECT_SAMPLE_FACTORS 92531 2015851 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=40.3; Gender=Male; wbc(cells/uL)=5500; hgb(g/dL)=13.4; rbc(cells/uL)=5260000 SUBJECT_SAMPLE_FACTORS 92532 2015852 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=54.3; Gender=Male; wbc(cells/uL)=4400; hgb(g/dL)=13.4; rbc(cells/uL)=4810000 SUBJECT_SAMPLE_FACTORS 92533 2015853 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=64.1; Gender=Male; wbc(cells/uL)=5400; hgb(g/dL)=14.9; rbc(cells/uL)=5910000 SUBJECT_SAMPLE_FACTORS 92534 2015854 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=41; Gender=Female; wbc(cells/uL)=2900; hgb(g/dL)=10.7; rbc(cells/uL)=4640000 SUBJECT_SAMPLE_FACTORS 92535 2015855 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=57.4; Gender=Female; wbc(cells/uL)=4500; hgb(g/dL)=13.6; rbc(cells/uL)=4840000 SUBJECT_SAMPLE_FACTORS 92536 2015856 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=52.4; Gender=Female; wbc(cells/uL)=4200; hgb(g/dL)=13; rbc(cells/uL)=4620000 SUBJECT_SAMPLE_FACTORS 92537 2015857 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=41.1; Gender=Male; wbc(cells/uL)=3000; hgb(g/dL)=13.1; rbc(cells/uL)=5100000 SUBJECT_SAMPLE_FACTORS 92538 2015858 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=25.4; Gender=Male; wbc(cells/uL)=5200; hgb(g/dL)=14.8; rbc(cells/uL)=5370000 SUBJECT_SAMPLE_FACTORS 92539 2015859 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=68.4; Gender=Female; wbc(cells/uL)=4200; hgb(g/dL)=12.9; rbc(cells/uL)=4570000 SUBJECT_SAMPLE_FACTORS 92540 2015860 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=36.3; Gender=Male; wbc(cells/uL)=2900; hgb(g/dL)=10.6; rbc(cells/uL)=3580000 SUBJECT_SAMPLE_FACTORS 92541 2015861 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=40.9; Gender=Male; wbc(cells/uL)=2600; hgb(g/dL)=14.7; rbc(cells/uL)=5030000 SUBJECT_SAMPLE_FACTORS 92542 2015862 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=27.3; Gender=Female; wbc(cells/uL)=3400; hgb(g/dL)=9.8; rbc(cells/uL)=3420000 SUBJECT_SAMPLE_FACTORS 92543 2015863 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=30.6; Gender=Female; wbc(cells/uL)=6100; hgb(g/dL)=8.6; rbc(cells/uL)=2920000 SUBJECT_SAMPLE_FACTORS 92544 2015864 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=18.7; Gender=Male; wbc(cells/uL)=7900; hgb(g/dL)=10.4; rbc(cells/uL)=3920000 SUBJECT_SAMPLE_FACTORS 92545 2015865 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=27.7; Gender=Male; wbc(cells/uL)=4600; hgb(g/dL)=13.6; rbc(cells/uL)=4830000 SUBJECT_SAMPLE_FACTORS 92546 2015866 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=22.5; Gender=Female; wbc(cells/uL)=8200; hgb(g/dL)=6.4; rbc(cells/uL)=2250000 SUBJECT_SAMPLE_FACTORS 92547 2015867 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=44; Gender=Male; wbc(cells/uL)=5300; hgb(g/dL)=7.3; rbc(cells/uL)=2670000 SUBJECT_SAMPLE_FACTORS 92548 2015878 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=85.6; Gender=Male; wbc(cells/uL)=5900; hgb(g/dL)=14.9; rbc(cells/uL)=5520000 SUBJECT_SAMPLE_FACTORS 92549 2015885 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=47.5; Gender=Male; wbc(cells/uL)=3100; hgb(g/dL)=14.8; rbc(cells/uL)=5150000 SUBJECT_SAMPLE_FACTORS 92551 2015886 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=61.1; Gender=Male; wbc(cells/uL)=12600; hgb(g/dL)=14.1; rbc(cells/uL)=4700000 SUBJECT_SAMPLE_FACTORS 92552 2015892 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=47.6; Gender=Male; wbc(cells/uL)=3700; hgb(g/dL)=13.1; rbc(cells/uL)=4290000 SUBJECT_SAMPLE_FACTORS 92553 2015893 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=14.4; Gender=Male; wbc(cells/uL)=1700; hgb(g/dL)=8.89; rbc(cells/uL)=3100000 SUBJECT_SAMPLE_FACTORS 92554 2015894 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=31; Gender=Male; wbc(cells/uL)=3900; hgb(g/dL)=14.6; rbc(cells/uL)=4940000 SUBJECT_SAMPLE_FACTORS 92555 2015895 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=39.6; Gender=Male; wbc(cells/uL)=6100; hgb(g/dL)=13.9; rbc(cells/uL)=5030000 SUBJECT_SAMPLE_FACTORS 92556 2015896 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=71.9; Gender=Male; wbc(cells/uL)=4900; hgb(g/dL)=15.1; rbc(cells/uL)=5440000 SUBJECT_SAMPLE_FACTORS 92557 2015897 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=55; Gender=Male; wbc(cells/uL)=6000; hgb(g/dL)=14.7; rbc(cells/uL)=5530000 SUBJECT_SAMPLE_FACTORS 92560 2015899 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=43; Gender=Female; wbc(cells/uL)=4000; hgb(g/dL)=10.4; rbc(cells/uL)=3580000 SUBJECT_SAMPLE_FACTORS 92561 2015900 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=30.9; Gender=Male; wbc(cells/uL)=6400; hgb(g/dL)=15.5; rbc(cells/uL)=5190000 SUBJECT_SAMPLE_FACTORS 92562 2015901 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=32.8; Gender=Female; wbc(cells/uL)=4000; hgb(g/dL)=9.8; rbc(cells/uL)=3580000 SUBJECT_SAMPLE_FACTORS 92563 2015904 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=38.2; Gender=Female; wbc(cells/uL)=4000; hgb(g/dL)=13.1; rbc(cells/uL)=4340000 SUBJECT_SAMPLE_FACTORS 92564 2015921 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=24.4; Gender=Male; wbc(cells/uL)=4600; hgb(g/dL)=15; rbc(cells/uL)=5860000 SUBJECT_SAMPLE_FACTORS 92565 2015922 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=14; Gender=Female; wbc(cells/uL)=3700; hgb(g/dL)=13.9; rbc(cells/uL)=5510000 SUBJECT_SAMPLE_FACTORS 92566 2015923 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=52.5; Gender=Male; wbc(cells/uL)=6700; hgb(g/dL)=14.6; rbc(cells/uL)=5390000 SUBJECT_SAMPLE_FACTORS 92567 2015924 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=38.5; Gender=Male; wbc(cells/uL)=5600; hgb(g/dL)=14.9; rbc(cells/uL)=4780000 SUBJECT_SAMPLE_FACTORS 92568 2015925 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=19.3; Gender=Female; wbc(cells/uL)=7400; hgb(g/dL)=14.7; rbc(cells/uL)=5000000 SUBJECT_SAMPLE_FACTORS 92569 2016028 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=<10; Gender=Female; wbc(cells/uL)=7000; hgb(g/dL)=7.3; rbc(cells/uL)=3270000 SUBJECT_SAMPLE_FACTORS 92570 2015926 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=14.8; Gender=Female; wbc(cells/uL)=7400; hgb(g/dL)=10.3; rbc(cells/uL)=3750000 SUBJECT_SAMPLE_FACTORS 92571 2015927 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=24; Gender=Male; wbc(cells/uL)=4600; hgb(g/dL)=15.4; rbc(cells/uL)=5480000 SUBJECT_SAMPLE_FACTORS 92572 2015928 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=47.9; Gender=Male; wbc(cells/uL)=3700; hgb(g/dL)=15.1; rbc(cells/uL)=5500000 SUBJECT_SAMPLE_FACTORS 92573 2015930 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=45.7; Gender=Female; wbc(cells/uL)=5500; hgb(g/dL)=10.6; rbc(cells/uL)=4080000 SUBJECT_SAMPLE_FACTORS 92574 2015931 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=46.6; Gender=Male; wbc(cells/uL)=5300; hgb(g/dL)=15.4; rbc(cells/uL)=5620000 SUBJECT_SAMPLE_FACTORS 92575 2015932 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=25.8; Gender=Female; wbc(cells/uL)=5900; hgb(g/dL)=9; rbc(cells/uL)=3060000 SUBJECT_SAMPLE_FACTORS 92576 2015977 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=44.1; Gender=Male; wbc(cells/uL)=7800; hgb(g/dL)=13.4; rbc(cells/uL)=4140000 SUBJECT_SAMPLE_FACTORS 92577 2015978 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=63.3; Gender=Female; wbc(cells/uL)=3700; hgb(g/dL)=14.1; rbc(cells/uL)=5540000 SUBJECT_SAMPLE_FACTORS 92578 2015980 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=29; Gender=Male; wbc(cells/uL)=5500; hgb(g/dL)=15.2; rbc(cells/uL)=5500000 SUBJECT_SAMPLE_FACTORS 92579 2015981 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=33.8; Gender=Male; wbc(cells/uL)=4100; hgb(g/dL)=13.4; rbc(cells/uL)=5210000 SUBJECT_SAMPLE_FACTORS 92580 2015984 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=39.3; Gender=Male; wbc(cells/uL)=8700; hgb(g/dL)=15.5; rbc(cells/uL)=5480000 SUBJECT_SAMPLE_FACTORS 92581 2015985 Current Malaria Infection:P.Vivax | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=49.2; Gender=Male; wbc(cells/uL)=6400; hgb(g/dL)=13.4; rbc(cells/uL)=4680000 SUBJECT_SAMPLE_FACTORS 92582 2015986 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=20.8; Gender=Female; wbc(cells/uL)=8100; hgb(g/dL)=13; rbc(cells/uL)=5410000 SUBJECT_SAMPLE_FACTORS 92583 2015987 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=23.5; Gender=Female; wbc(cells/uL)=10100; hgb(g/dL)=10.9; rbc(cells/uL)=3990000 SUBJECT_SAMPLE_FACTORS 92584 2015988 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=39.3; Gender=Male; wbc(cells/uL)=5100; hgb(g/dL)=14; rbc(cells/uL)=5750000 SUBJECT_SAMPLE_FACTORS 92585 2016005 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=43.7; Gender=Male; wbc(cells/uL)=1900; hgb(g/dL)=15.5; rbc(cells/uL)=5290000 SUBJECT_SAMPLE_FACTORS 92586 2016006 Current Malaria Infection:P.Vivax | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=36.9; Gender=Male; wbc(cells/uL)=4600; hgb(g/dL)=15.5; rbc(cells/uL)=5770000 SUBJECT_SAMPLE_FACTORS 92587 2016007 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=28; Gender=Male; wbc(cells/uL)=5600; hgb(g/dL)=14.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92588 2016008 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=29; Gender=Male; wbc(cells/uL)=6200; hgb(g/dL)=14.1; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92589 2016009 Current Malaria Infection:None | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=26; Gender=Male; wbc(cells/uL)=8500; hgb(g/dL)=13.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92590 2016010 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=-; Gender=Female; wbc(cells/uL)=7600; hgb(g/dL)=12.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92591 2016011 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=-; Gender=Female; wbc(cells/uL)=6300; hgb(g/dL)=12.1; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92592 2016012 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=-; Gender=Female; wbc(cells/uL)=7700; hgb(g/dL)=12.7; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92593 2016013 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=-; Gender=Male; wbc(cells/uL)=9300; hgb(g/dL)=13.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92594 2016014 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=-; Gender=Female; wbc(cells/uL)=5500; hgb(g/dL)=11.8; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92595 2016015 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=-; Gender=Female; wbc(cells/uL)=8500; hgb(g/dL)=13.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92596 2016016 Current Malaria Infection:None | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=40; Gender=Male; wbc(cells/uL)=5300; hgb(g/dL)=12.8; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92597 2016017 Current Malaria Infection:None | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=20; Gender=Male; wbc(cells/uL)=9600; hgb(g/dL)=14.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92598 2016018 Current Malaria Infection:None | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=35; Gender=Male; wbc(cells/uL)=6000; hgb(g/dL)=15.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92599 2016019 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=36; Gender=Female; wbc(cells/uL)=5800; hgb(g/dL)=14.4; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92600 2016020 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=31; Gender=Male; wbc(cells/uL)=6300; hgb(g/dL)=15.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92601 2016021 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=40; Gender=Male; wbc(cells/uL)=5100; hgb(g/dL)=14.4; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92602 2016022 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=19; Gender=Female; wbc(cells/uL)=10200; hgb(g/dL)=11; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92603 2016023 Current Malaria Infection:None | Prior Malaria Infection:YES | Chloroquine Resistance:N/A Age=45; Gender=Male; wbc(cells/uL)=12000; hgb(g/dL)=14.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92604 2016024 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=32; Gender=Male; wbc(cells/uL)=7700; hgb(g/dL)=15.6; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92605 2016025 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=29; Gender=Female; wbc(cells/uL)=6700; hgb(g/dL)=12.3; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS 92606 2016026 Current Malaria Infection:None | Prior Malaria Infection:NO | Chloroquine Resistance:N/A Age=38; Gender=Female; wbc(cells/uL)=7500; hgb(g/dL)=12.5; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129337 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129341 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129339 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129343 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129340 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 853678 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129336 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2127215 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129344 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129342 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129346 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129335 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129345 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129338 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS REe6 2129347 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991100021 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991100022 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200042 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200043 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200044 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200045 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200046 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200047 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200048 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200049 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200050 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200051 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200052 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200053 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200054 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200055 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200056 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200057 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200058 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200059 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200060 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200061 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200062 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- SUBJECT_SAMPLE_FACTORS N/A 9991200041 Current Malaria Infection:None | Prior Malaria Infection:N/A | Chloroquine Resistance:N/A Age=N/A; Gender=N/A; wbc(cells/uL)=-; hgb(g/dL)=-; rbc(cells/uL)=- #COLLECTION CO:COLLECTION_SUMMARY none CO:SAMPLE_TYPE Blood CO:COLLECTION_FREQUENCY Once or Twice #TREATMENT TR:TREATMENT_SUMMARY None #SAMPLEPREP SP:SAMPLEPREP_SUMMARY aliquots of 30ul sample were mixed with 100ul acetonitrile and 2.5ul internal SP:SAMPLEPREP_SUMMARY standard. Keep on ice for 30 minutes and vortex every 15 minutes. Centrifuge for SP:SAMPLEPREP_SUMMARY 10 minutes at 13.2rpm and 4C. Using a pipette, 100ul of supernatant was removed SP:SAMPLEPREP_SUMMARY and placed into autosampler vials for the mass spectrometer. SP:SAMPLEPREP_PROTOCOL_FILENAME Metab_Sample_Preparation_Plasma_serum_v1_May_17_2013.docx SP:PROCESSING_METHOD Precipitation of protein, centrifuge, and remove supernatant SP:PROCESSING_STORAGE_CONDITIONS on ice SP:EXTRACTION_METHOD 1:2 sample:acetonitrile SP:EXTRACT_STORAGE Pipette supernatant into autosampler vials for mass spectrometer SP:SAMPLE_SPIKING C18 standards: Caffeine and Diethyl-toluamide. Stable isotopes: SP:SAMPLE_SPIKING [13C6]-D-glucose, [15N]-indole, [1,2-13C2]-palmitic acid, SP:SAMPLE_SPIKING [15N,13C5]-L-methionine, [2-15N]-L-lysine dihydrochloride, [15N]-choline SP:SAMPLE_SPIKING chloride, [13C5]-L-glutamic acid, [13C7]-benzoic acid, [15N]-L-tyrosine, SP:SAMPLE_SPIKING [15N2]-uracil, [3,4-13C2]-cholesterol, [3,3-13C2]-cystine, SP:SAMPLE_SPIKING [trimethyl-13C3]-caffeine, [U-13C5, U-15N2]-L-glutamine. #CHROMATOGRAPHY CH:CHROMATOGRAPHY_SUMMARY Positive untargeted anion exchange chromatography (AE column) CH:CHROMATOGRAPHY_TYPE Anion exchange CH:INSTRUMENT_NAME Thermo Accela CTC CH:COLUMN_NAME Hamilton Anion Exchange HPLC Columns, 100x2.1, 2.6µm, Thermo Fisher CH:FLOW_GRADIENT A: 0-2mins = 10%, 2-7mins = gradient to 80%, 7-10mins = 80%. B: 0-2mins = 80%, CH:FLOW_GRADIENT 2-7mins = gradient to 10%, 7-10mins = 10%. C: 0-10mins = 10% CH:FLOW_RATE 350?L/min CH:COLUMN_TEMPERATURE 30 CH:METHODS_FILENAME Metab_Orbitrap_Setup_v2_26Jun2013.docx CH:SOLVENT_A LCMS H20 CH:SOLVENT_B LCMS Acetonitrile CH:INTERNAL_STANDARD [13C6]-D-glucose, [15N]-indole, [1,2-13C2]-palmitic acid, CH:INTERNAL_STANDARD [15N,13C5]-L-methionine, [2-15N]-L-lysine dihydrochloride, [15N]-choline CH:INTERNAL_STANDARD chloride, [13C5]-L-glutamic acid, [13C7]-benzoic acid, [15N]-L-tyrosine, CH:INTERNAL_STANDARD [15N2]-uracil, [3,4-13C2]-cholesterol, [3,3-13C2]-cystine, CH:INTERNAL_STANDARD [trimethyl-13C3]-caffeine, [U-13C5, U-15N2]-L-glutamine CH:SAMPLE_INJECTION 10?L CH:SAMPLING_CONE HESI probe with S-lens combination for ESI CH:ANALYTICAL_TIME 10 minutes CH:CAPILLARY_VOLTAGE 4.6 kV CH:OVEN_TEMPERATURE 45 C CH:RUNNING_VOLTAGE 45 CH:WEAK_WASH_SOLVENT_NAME H20 with 10% methanol CH:SAMPLE_SYRINGE_SIZE 20?L #ANALYSIS AN:ANALYSIS_TYPE MS AN:SOFTWARE_VERSION Thermo Excalibur 2.2 SP1 AN:ANALYSIS_PROTOCOL_FILE Metab_Orbitrap_Setup_v2_26Jun2013.docx #MS MS:INSTRUMENT_NAME Thermo LTQ-FT MS:INSTRUMENT_TYPE Single quadrupole MS:MS_TYPE ESI MS:ION_MODE POSITIVE MS:MS_COMMENTS AE Pos: technical triplicates for each sample MS:CAPILLARY_VOLTAGE 4.45 MS:COLLISION_GAS N2 MS:GAS_PRESSURE 50 MS:IONIZATION electrospray ionization MS:MASS_ACCURACY 5 ppm MS:SOURCE_TEMPERATURE 48 MS:SPRAY_VOLTAGE 3.5 MS:ATOM_GUN_CURRENT 1000000 MS:DATAFORMAT .raw, .cdf MS:PROBE_TIP HESI MS:RESOLUTION_SETTING 60000 MS:SCAN_RANGE_MOVERZ 85-2000 MS:MS_RESULTS_FILE ST000578_AN000889_Results.zip #END